白奥维达中国基金首席合伙人杨志简介

　　Dr. Zhi Yang

　　Managing Partner of BioVeda China

　　杨志博士

　　白奥维达中国基金首席合伙人

　　Dr. Zhi Yang is Managing Partner of BioVeda China. He has over two decades of experience in biotechnology, having held senior scientific and management positions in a variety of biotech and pharmaceutical companies, including Sinogen, Incyte Pharmaceuticals, Prolinx, Sandoz Pharmaceuticals, and Systemix. During his industry years, he was interim CEO, VP of Business Development, VP of R&D and the Director of Molecular Biology, Group Leader and Senior/Principal Scientist. As an entrepreneur, he co-founded BioChain Institute, Genex Biosciences and Crimson Pharmaceuticals. He is also the Principal Inventor of more than 10

　　U.S. and international patents.

　　Prior to joining industry, Dr. Zhi was a senior associate fellow and faculty member at Rockefeller University. He holds a M.A., Ph.D. in Biochemistry and Molecular Biology from Harvard University, where his thesis advisors were Dr. Walter Gilbert, a Nobel laureate, and Dr. Jack Strominger, a world-renowned immunologist.

　　杨志博士现为白奥维达中国基金首席合伙人。他在生物科技领域拥有超过20年的经验，并在许多生物科技与制药企业担任过高级研究与管理职务，包括Sinogen, Incyte Pharmaceuticals, Prolinx, Sandoz Pharmaceuticals及Systemix。他曾担任临时行政总裁、业务发展部副总裁、研发部副总裁、细胞生物学总监以及高级/首席科学家等。作为企业家，他联合创立了BioChain Institute, Genex Biosciences以及Crimson Pharmaceuticals。作为首席发明家，他拥有美国以及国际超过10项产品专利。

　　在加入生物科技领域前，杨志博士是洛克斐勒大學的高级研究员。他拥有哈佛大学生物化学以及细胞生物学硕士以及博士学位；他的论文导师是诺贝尔奖获得者Walter Gilbert博士以及世界著名免疫学家Jack Strominger博士。